ETF Holdings Breakdown of RLAY

RLAY institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	112,480	USD 581,522
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	66,868	USD 345,708
2025-09-26	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	173,963	USD 899,389
2025-09-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	97,802	USD 505,636
2025-09-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	97,802	USD 505,636
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	5,431	USD 28,078 15.3%
Total =		554,346	USD 2,865,969

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with RLAY

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $17.25 Consensus PT from Analysts

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the […] - 2025-08-27 02:54:54

XTX Topco Ltd Purchases 20,161 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

XTX Topco Ltd lifted its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 33.7% in the 1st quarter, HoldingsChannel.com reports. The fund owned 79,913 shares of the company’s stock after buying an additional 20,161 shares during the period. XTX Topco Ltd’s holdings in Relay Therapeutics were worth $209,000 as of its most recent […] - 2025-08-14 04:22:55

Raymond James Financial Has Lowered Expectations for Relay Therapeutics (NASDAQ:RLAY) Stock Price

Relay Therapeutics (NASDAQ:RLAY – Free Report) had its target price reduced by Raymond James Financial from $29.00 to $19.00 in a research report report published on Friday morning,Benzinga reports. Raymond James Financial currently has a strong-buy rating on the stock. RLAY has been the subject of several other research reports. Wells Fargo & Company started […] - 2025-08-11 03:50:57

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve research firms that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year […] - 2025-07-30 02:46:52

Relay Therapeutics (NASDAQ:RLAY) versus Incannex Healthcare (NASDAQ:IXHL) Head-To-Head Review

Incannex Healthcare (NASDAQ:IXHL – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 0.4% of Incannex […] - 2025-07-29 02:49:02

DekaBank Deutsche Girozentrale Buys 8,937 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

DekaBank Deutsche Girozentrale boosted its stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 14.9% during the 1st quarter, HoldingsChannel reports. The fund owned 68,937 shares of the company’s stock after purchasing an additional 8,937 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Relay Therapeutics were worth $181,000 at the end […] - 2025-07-15 06:23:59

Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Target Price at $17.67

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The […] - 2025-07-08 02:38:55

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $17.67 Average Price Target from Analysts

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month […] - 2025-06-13 02:32:49

Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Holdings Boosted by Squarepoint Ops LLC

Squarepoint Ops LLC boosted its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 535.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 162,588 shares of the company’s stock after purchasing an additional 137,020 shares during the quarter. Squarepoint Ops […] - 2025-06-03 05:38:55

Northern Trust Corp Raises Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)

Northern Trust Corp boosted its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 24.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,169,979 shares of the company’s stock after acquiring an additional 231,713 shares during the quarter. Northern Trust Corp’s holdings in Relay Therapeutics were worth $4,820,000 at the […] - 2025-05-22 04:22:54

Graham Capital Management L.P. Acquires New Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)

Graham Capital Management L.P. acquired a new stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 31,569 shares of the company’s stock, valued at approximately $130,000. A number of other large investors have also added to […] - 2025-05-20 05:10:52

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $17.67 Average PT from Brokerages

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 12-month price target […] - 2025-05-19 02:30:55

MetLife Investment Management LLC Acquires 16,477 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

MetLife Investment Management LLC increased its holdings in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 28.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 74,166 shares of the company’s stock after buying an additional 16,477 shares during the quarter. MetLife Investment Management LLC’s holdings in Relay Therapeutics were worth $306,000 […] - 2025-05-08 04:56:55

189,046 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 189,046 shares of the company’s stock, valued at approximately $779,000. Other institutional investors also recently modified their holdings of the company. Barclays PLC lifted its position in shares […] - 2025-05-07 05:46:50

Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Reduced by Wells Fargo & Company MN

Wells Fargo & Company MN trimmed its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 45.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 71,425 shares of the company’s stock after selling 59,042 shares during the period. Wells Fargo & Company MN’s holdings in Relay Therapeutics were worth $294,000 as of […] - 2025-05-07 04:52:58

Renaissance Technologies LLC Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)

Renaissance Technologies LLC grew its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 130.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,549,190 shares of the company’s stock after buying an additional 878,095 shares during the […] - 2025-04-20 05:00:52

JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)

JPMorgan Chase & Co. decreased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 9.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,978,443 shares of the company’s stock after selling 539,073 shares during the period. JPMorgan Chase & […] - 2025-04-11 06:20:51

American Century Companies Inc. Purchases 51,499 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

American Century Companies Inc. increased its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 23.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 272,166 shares of the company’s stock after buying an additional 51,499 shares during the quarter. American Century Companies Inc.’s holdings in Relay Therapeutics were worth $1,121,000 at the […] - 2025-04-11 04:34:48

Prudential Financial Inc. Buys 173,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

Prudential Financial Inc. grew its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 45.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 549,645 shares of the company’s stock after acquiring an additional 173,000 shares during the quarter. Prudential Financial […] - 2025-04-04 04:37:00

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by Teacher Retirement System of Texas

Teacher Retirement System of Texas grew its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 19.5% in the fourth quarter, Holdings Channel reports. The fund owned 33,720 shares of the company’s stock after purchasing an additional 5,492 shares during the period. Teacher Retirement System of Texas’ holdings in Relay Therapeutics were worth $139,000 […] - 2025-04-03 04:54:50

Cibc World Markets Corp Buys New Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)

Cibc World Markets Corp purchased a new position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 11,388 shares of the company’s stock, valued at approximately $47,000. Several other large investors also recently bought and […] - 2025-03-28 06:18:47

Bank of New York Mellon Corp Purchases 50,190 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

Bank of New York Mellon Corp raised its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 18.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 328,897 shares of the company’s stock after acquiring an additional 50,190 shares […] - 2025-03-24 05:10:52

Relay Therapeutics (NASDAQ:RLAY) vs. Kyverna Therapeutics (NASDAQ:KYTX) Financial Survey

Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Insider & Institutional Ownership 18.1% of Kyverna […] - 2025-03-21 03:51:04

Los Angeles Capital Management LLC Acquires 20,880 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

Los Angeles Capital Management LLC increased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 65.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,770 shares of the company’s stock after purchasing an additional 20,880 shares during the period. […] - 2025-03-05 08:41:42

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. raised its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 37.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,491 shares of the company’s stock after purchasing an additional 9,740 shares […] - 2025-02-04 06:53:08

Back to Listing

Disclaimer